| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.47e-05 | 2 | 77 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.47e-05 | 2 | 77 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.39e-05 | 3 | 77 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | SMAD binding | 3.42e-04 | 86 | 77 | 4 | GO:0046332 | |
| GeneOntologyCellularComponent | chromatin | HOXA13 NR2C1 KLF12 NSMF STAG1 INCENP CECR2 MORF4L1 GATA4 POU3F4 PRKDC FOXN3 ONECUT1 CREBBP EP300 SMAD1 DNMT1 | 2.15e-05 | 1480 | 77 | 17 | GO:0000785 |
| HumanPheno | Abnormal hallux phalanx morphology | 4.04e-06 | 46 | 28 | 5 | HP:0010057 | |
| HumanPheno | Deep plantar creases | 4.10e-06 | 21 | 28 | 4 | HP:0001869 | |
| HumanPheno | Broad hallux phalanx | 7.20e-06 | 24 | 28 | 4 | HP:0010059 | |
| HumanPheno | Minor feet anomalies | 1.01e-05 | 26 | 28 | 4 | HP:0010613 | |
| HumanPheno | Abnormal feet morphology | 1.01e-05 | 26 | 28 | 4 | HP:0010611 | |
| HumanPheno | Broad distal phalanx of finger | 1.18e-05 | 27 | 28 | 4 | HP:0009836 | |
| HumanPheno | Full cheeks | 1.23e-05 | 151 | 28 | 7 | HP:0000293 | |
| HumanPheno | Benign neoplasm of the central nervous system | 1.73e-05 | 105 | 28 | 6 | HP:0100835 | |
| HumanPheno | Abnormal nasal bridge morphology | GHR SETD2 FAT4 NSMF STAG1 CCBE1 NUP88 GATA4 ABCC9 FBXO11 PRKDC GNAS MN1 CREBBP EP300 MAPK8IP3 | 1.77e-05 | 1029 | 28 | 16 | HP:0000422 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 1.83e-05 | 298 | 28 | 9 | HP:0006494 | |
| HumanPheno | Flat face | 1.83e-05 | 106 | 28 | 6 | HP:0012368 | |
| HumanPheno | Syringomyelia | 2.68e-05 | 33 | 28 | 4 | HP:0003396 | |
| HumanPheno | Plantar crease between first and second toes | 2.91e-05 | 2 | 28 | 2 | HP:0008107 | |
| HumanPheno | Pericardial lymphangiectasia | 2.91e-05 | 2 | 28 | 2 | HP:0005183 | |
| HumanPheno | Aortic isthmus hypoplasia | 2.91e-05 | 2 | 28 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 2.91e-05 | 2 | 28 | 2 | HP:0001042 | |
| HumanPheno | Abnormality of skeletal maturation | 3.21e-05 | 405 | 28 | 10 | HP:0000927 | |
| HumanPheno | Abnormality of the first metatarsal bone | 4.10e-05 | 13 | 28 | 3 | HP:0010054 | |
| HumanPheno | Abnormality of toe proximal phalanx | 5.20e-05 | 14 | 28 | 3 | HP:0010184 | |
| HumanPheno | Delayed skeletal maturation | 6.90e-05 | 352 | 28 | 9 | HP:0002750 | |
| HumanPheno | Low-set ears | FAT4 STAG1 CCBE1 NUP88 GATA4 ANO1 FBXO11 PRKDC POMK MN1 CREBBP EP300 MAPK8IP3 | 7.06e-05 | 761 | 28 | 13 | HP:0000369 |
| HumanPheno | Meningioma | 8.53e-05 | 44 | 28 | 4 | HP:0002858 | |
| HumanPheno | Laryngeal cartilage malformation | 8.71e-05 | 3 | 28 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 8.71e-05 | 3 | 28 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 8.71e-05 | 3 | 28 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 8.71e-05 | 3 | 28 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 8.71e-05 | 3 | 28 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 8.71e-05 | 3 | 28 | 2 | HP:0005895 | |
| HumanPheno | Spinal cord lesion | 1.02e-04 | 46 | 28 | 4 | HP:0100561 | |
| HumanPheno | Broad phalanx of the toes | 1.11e-04 | 47 | 28 | 4 | HP:0010174 | |
| HumanPheno | Chiari type I malformation | 1.20e-04 | 48 | 28 | 4 | HP:0007099 | |
| HumanPheno | Broad phalanx | 1.21e-04 | 148 | 28 | 6 | HP:0006009 | |
| HumanPheno | Broad phalanges of the hand | 1.21e-04 | 148 | 28 | 6 | HP:0009768 | |
| HumanPheno | Hirsutism | 1.24e-04 | 216 | 28 | 7 | HP:0001007 | |
| HumanPheno | Broad finger | 1.50e-04 | 154 | 28 | 6 | HP:0001500 | |
| HumanPheno | Abnormal midface morphology | GHR AMPD2 SETD2 FAT4 CCBE1 GATA4 FBXO11 GNAS MN1 CREBBP EP300 MAPK8IP3 | 1.61e-04 | 704 | 28 | 12 | HP:0000309 |
| HumanPheno | Abnormal proximal phalanx morphology of the hand | 1.65e-04 | 52 | 28 | 4 | HP:0009834 | |
| HumanPheno | Increased body weight | GHR SETD2 GATA4 ABCC9 FBXO11 POU3F4 GNAS CREBBP EP300 MAPK8IP3 | 1.67e-04 | 491 | 28 | 10 | HP:0004324 |
| HumanPheno | Broad long bones | 1.67e-04 | 157 | 28 | 6 | HP:0005622 | |
| HumanPheno | Trichiasis | 1.74e-04 | 4 | 28 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.74e-04 | 4 | 28 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.74e-04 | 4 | 28 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.74e-04 | 4 | 28 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.74e-04 | 4 | 28 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.74e-04 | 4 | 28 | 2 | HP:0031207 | |
| HumanPheno | Abnormal metatarsal morphology | 1.79e-04 | 159 | 28 | 6 | HP:0001832 | |
| HumanPheno | Wide nasal bridge | SETD2 FAT4 CCBE1 NUP88 GATA4 ABCC9 FBXO11 PRKDC CREBBP EP300 | 2.22e-04 | 508 | 28 | 10 | HP:0000431 |
| HumanPheno | Abnormality of the incisor | 2.60e-04 | 108 | 28 | 5 | HP:0000676 | |
| HumanPheno | Abnormal lower limb bone morphology | GHR HOXA13 FAT4 CCBE1 NUP88 GATA4 ABCC9 FBXO11 GNAS POMK CREBBP EP300 MAPK8IP3 | 2.75e-04 | 866 | 28 | 13 | HP:0040069 |
| HumanPheno | Pulmonary lymphangiectasia | 2.88e-04 | 5 | 28 | 2 | HP:0006521 | |
| HumanPheno | Intestinal lymphangiectasia | 2.88e-04 | 5 | 28 | 2 | HP:0002593 | |
| HumanPheno | Abnormal pulmonary lymphatics | 2.88e-04 | 5 | 28 | 2 | HP:0006529 | |
| HumanPheno | Short first metatarsal | 2.88e-04 | 5 | 28 | 2 | HP:0010105 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 2.88e-04 | 5 | 28 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 2.88e-04 | 5 | 28 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 2.88e-04 | 5 | 28 | 2 | HP:0030421 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 2.93e-04 | 174 | 28 | 6 | HP:0009832 | |
| HumanPheno | Obesity | 2.95e-04 | 425 | 28 | 9 | HP:0001513 | |
| HumanPheno | Hypertrichosis | 2.95e-04 | 425 | 28 | 9 | HP:0000998 | |
| HumanPheno | Duane anomaly | 3.16e-04 | 25 | 28 | 3 | HP:0009921 | |
| HumanPheno | Incomitant strabismus | 3.16e-04 | 25 | 28 | 3 | HP:0025068 | |
| HumanPheno | Abnormal incisor morphology | 3.27e-04 | 62 | 28 | 4 | HP:0011063 | |
| HumanPheno | Short metatarsal | 3.27e-04 | 62 | 28 | 4 | HP:0010743 | |
| HumanPheno | Neoplasm of the central nervous system | 3.32e-04 | 178 | 28 | 6 | HP:0100006 | |
| HumanPheno | Short toe | 3.63e-04 | 116 | 28 | 5 | HP:0001831 | |
| HumanPheno | Prominent forehead | 4.00e-04 | 261 | 28 | 7 | HP:0011220 | |
| HumanPheno | Aplasia/Hypoplasia of metatarsal bones | 4.17e-04 | 66 | 28 | 4 | HP:0001964 | |
| HumanPheno | Large foramen magnum | 4.31e-04 | 6 | 28 | 2 | HP:0002700 | |
| HumanPheno | Deeply set eye | 4.49e-04 | 266 | 28 | 7 | HP:0000490 | |
| HumanPheno | Flared metaphysis | 4.85e-04 | 191 | 28 | 6 | HP:0003015 | |
| HumanPheno | Broad eyebrow | 4.94e-04 | 29 | 28 | 3 | HP:0011229 | |
| HumanPheno | Abnormality of the outer ear | HOXA13 AMPD2 FAT4 STAG1 CCBE1 NUP88 GATA4 ANO1 FBXO11 POU3F4 PRKDC POMK MN1 CREBBP EP300 MAPK8IP3 | 5.08e-04 | 1337 | 28 | 16 | HP:0000356 |
| HumanPheno | Neoplasm of the nervous system | 5.42e-04 | 195 | 28 | 6 | HP:0004375 | |
| HumanPheno | Long eyelashes | 5.93e-04 | 129 | 28 | 5 | HP:0000527 | |
| HumanPheno | Deviated nasal septum | 6.02e-04 | 7 | 28 | 2 | HP:0004411 | |
| HumanPheno | Hypoplastic iliac wing | 6.03e-04 | 31 | 28 | 3 | HP:0002866 | |
| HumanPheno | Abnormal toe phalanx morphology | 6.14e-04 | 130 | 28 | 5 | HP:0010161 | |
| HumanPheno | Abnormal cheek morphology | 6.40e-04 | 282 | 28 | 7 | HP:0004426 | |
| HumanPheno | Functional abnormality of the inner ear | SETD2 FAT4 NSMF CCBE1 GATA4 ABCC9 POU3F4 PRKDC GNAS POMK CREBBP EP300 VCL DNMT1 | 6.53e-04 | 1077 | 28 | 14 | HP:0011389 |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | 6.67e-04 | 474 | 28 | 9 | HP:0006493 | |
| HumanPheno | Abnormal location of ears | FAT4 STAG1 CCBE1 NUP88 GATA4 ANO1 FBXO11 PRKDC POMK MN1 CREBBP EP300 MAPK8IP3 | 6.70e-04 | 945 | 28 | 13 | HP:0000357 |
| HumanPheno | Lymphedema | 7.14e-04 | 76 | 28 | 4 | HP:0001004 | |
| HumanPheno | Frontal upsweep of hair | 7.27e-04 | 33 | 28 | 3 | HP:0002236 | |
| HumanPheno | Abnormality of upper limb joint | GHR HOXA13 SETD2 FAT4 STAG1 CCBE1 NUP88 ABCC9 FBXO11 CREBBP EP300 | 7.51e-04 | 705 | 28 | 11 | HP:0009810 |
| HumanPheno | Sensorineural hearing impairment | SETD2 FAT4 NSMF CCBE1 ABCC9 POU3F4 PRKDC GNAS POMK CREBBP EP300 VCL DNMT1 | 7.67e-04 | 958 | 28 | 13 | HP:0000407 |
| HumanPheno | Aplasia/hypoplasia of the 1st metatarsal | 7.99e-04 | 8 | 28 | 2 | HP:0010067 | |
| HumanPheno | Short phalanx of hallux | 7.99e-04 | 8 | 28 | 2 | HP:0010111 | |
| HumanPheno | Aplasia/hypoplasia of proximal toe phalanx | 7.99e-04 | 8 | 28 | 2 | HP:0010203 | |
| HumanPheno | Abnormality of the inner ear | SETD2 FAT4 NSMF CCBE1 GATA4 ABCC9 POU3F4 PRKDC GNAS POMK CREBBP EP300 VCL DNMT1 | 8.34e-04 | 1102 | 28 | 14 | HP:0000359 |
| HumanPheno | Abnormality of globe location or size | SETD2 FAT4 NSMF STAG1 CCBE1 NUP88 GATA4 ABCC9 FBXO11 PRKDC POMK MN1 CREBBP EP300 MAPK8IP3 | 8.48e-04 | 1246 | 28 | 15 | HP:0000489 |
| HumanPheno | Aplasia/Hypoplasia of toe | 8.62e-04 | 140 | 28 | 5 | HP:0001991 | |
| HumanPheno | Abnormal dental morphology | 9.08e-04 | 299 | 28 | 7 | HP:0006482 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 9.41e-04 | 36 | 28 | 3 | HP:0009617 | |
| HumanPheno | Abnormal scrotum morphology | 9.48e-04 | 143 | 28 | 5 | HP:0000045 | |
| HumanPheno | Truncal obesity | 9.52e-04 | 82 | 28 | 4 | HP:0001956 | |
| HumanPheno | Abnormality of globe location | SETD2 FAT4 NSMF STAG1 CCBE1 NUP88 GATA4 ABCC9 FBXO11 PRKDC MN1 CREBBP EP300 MAPK8IP3 | 1.01e-03 | 1122 | 28 | 14 | HP:0100886 |
| HumanPheno | Pilomatrixoma | 1.02e-03 | 9 | 28 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 1.02e-03 | 9 | 28 | 2 | HP:0002341 | |
| HumanPheno | Short phalanx of finger | 1.04e-03 | 306 | 28 | 7 | HP:0009803 | |
| HumanPheno | Supernumerary tooth | 1.09e-03 | 85 | 28 | 4 | HP:0011069 | |
| MousePheno | decreased circulating glucagon level | 2.07e-06 | 20 | 66 | 4 | MP:0002696 | |
| MousePheno | perinatal lethality | GHR CYP1A2 ARHGAP5 CACNB1 FAT4 CELSR3 CECR2 MORF4L1 GATA4 FBXO11 GNAS MN1 CREBBP EP300 RUFY3 MAPK8IP3 BAHCC1 MGRN1 | 3.09e-06 | 1130 | 66 | 18 | MP:0002081 |
| MousePheno | abnormal circulating glucagon level | 3.64e-05 | 40 | 66 | 4 | MP:0002695 | |
| MousePheno | thin myocardium | 4.93e-05 | 85 | 66 | 5 | MP:0002652 | |
| MousePheno | cyanosis | 9.11e-05 | 226 | 66 | 7 | MP:0001575 | |
| MousePheno | thin ventricle myocardium compact layer | 1.08e-04 | 20 | 66 | 3 | MP:0010556 | |
| MousePheno | perinatal lethality, incomplete penetrance | 1.15e-04 | 503 | 66 | 10 | MP:0011090 | |
| MousePheno | abnormal interatrial septum morphology | 1.48e-04 | 107 | 66 | 5 | MP:0000282 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | GHR CYP1A2 HOXA13 CECR2 GATA4 FBXO11 PRKDC FOXN3 GNAS ONECUT1 MN1 CREBBP EP300 BAHCC1 MGRN1 | 1.86e-04 | 1124 | 66 | 15 | MP:0011112 |
| MousePheno | abnormal oxygen level | 1.97e-04 | 256 | 66 | 7 | MP:0001574 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | HOXA13 ARHGAP5 CACNB1 FAT4 CELSR3 STAG1 MORF4L1 GATA4 ANO1 FBXO11 GNAS MN1 CREBBP EP300 RUFY3 MAPK8IP3 | 2.10e-04 | 1269 | 66 | 16 | MP:0011111 |
| MousePheno | abnormal extraembryonic tissue morphology | GHR HOXA13 BCL9L SETD2 STAG1 INCENP CCBE1 GATA4 GAB3 CREBBP EP300 SMAD1 DNMT1 | 2.75e-04 | 908 | 66 | 13 | MP:0002086 |
| Domain | Nuc_rcpt_coact_CREBbp | 1.59e-05 | 2 | 75 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.59e-05 | 2 | 75 | 2 | PF08214 | |
| Domain | KIX | 1.59e-05 | 2 | 75 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.59e-05 | 2 | 75 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.59e-05 | 2 | 75 | 2 | IPR031162 | |
| Domain | DUF902 | 1.59e-05 | 2 | 75 | 2 | PF06001 | |
| Domain | - | 1.59e-05 | 2 | 75 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.59e-05 | 2 | 75 | 2 | IPR010303 | |
| Domain | - | 1.59e-05 | 2 | 75 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.59e-05 | 2 | 75 | 2 | PF09030 | |
| Domain | - | 1.59e-05 | 2 | 75 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.59e-05 | 2 | 75 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.59e-05 | 2 | 75 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.59e-05 | 2 | 75 | 2 | IPR013178 | |
| Domain | KAT11 | 1.59e-05 | 2 | 75 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.59e-05 | 2 | 75 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.59e-05 | 2 | 75 | 2 | IPR003101 | |
| Domain | KIX | 1.59e-05 | 2 | 75 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.59e-05 | 2 | 75 | 2 | PS51727 | |
| Domain | Bromodomain_CS | 1.51e-04 | 26 | 75 | 3 | IPR018359 | |
| Domain | Nuc_rcpt_coact | 2.36e-04 | 6 | 75 | 2 | IPR009110 | |
| Domain | BROMODOMAIN_1 | 4.38e-04 | 37 | 75 | 3 | PS00633 | |
| Domain | Bromodomain | 4.74e-04 | 38 | 75 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 5.94e-04 | 41 | 75 | 3 | PS50014 | |
| Domain | BROMO | 6.38e-04 | 42 | 75 | 3 | SM00297 | |
| Domain | Bromodomain | 6.38e-04 | 42 | 75 | 3 | IPR001487 | |
| Domain | - | 6.38e-04 | 42 | 75 | 3 | 1.20.920.10 | |
| Domain | BAH | 8.55e-04 | 11 | 75 | 2 | SM00439 | |
| Domain | BAH | 8.55e-04 | 11 | 75 | 2 | PF01426 | |
| Domain | BAH | 8.55e-04 | 11 | 75 | 2 | PS51038 | |
| Domain | BAH_dom | 8.55e-04 | 11 | 75 | 2 | IPR001025 | |
| Domain | CS | 1.40e-03 | 14 | 75 | 2 | PF04969 | |
| Domain | CS_dom | 1.84e-03 | 16 | 75 | 2 | IPR007052 | |
| Domain | CS | 1.84e-03 | 16 | 75 | 2 | PS51203 | |
| Domain | ZZ | 2.34e-03 | 18 | 75 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.34e-03 | 18 | 75 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.34e-03 | 18 | 75 | 2 | PS01357 | |
| Domain | Znf_ZZ | 2.60e-03 | 19 | 75 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.60e-03 | 19 | 75 | 2 | SM00291 | |
| Domain | Pentatricopeptide_repeat | 3.81e-03 | 23 | 75 | 2 | IPR002885 | |
| Domain | - | 3.81e-03 | 23 | 75 | 2 | 2.60.40.790 | |
| Domain | UBQ-conjugating_AS | 4.50e-03 | 25 | 75 | 2 | IPR023313 | |
| Domain | HSP20-like_chaperone | 4.86e-03 | 26 | 75 | 2 | IPR008978 | |
| Domain | - | 5.23e-03 | 27 | 75 | 2 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 6.02e-03 | 29 | 75 | 2 | IPR010982 | |
| Domain | ASX_HYDROXYL | 7.61e-03 | 100 | 75 | 3 | PS00010 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 5.68e-06 | 65 | 56 | 5 | M39682 | |
| Pathway | REACTOME_SUMOYLATION | 9.28e-06 | 189 | 56 | 7 | M27214 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.21e-05 | 16 | 56 | 3 | M27121 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | NR2C1 UBE2G2 UBE2H STAG1 INCENP RBBP5 SHISA5 NICN1 NUP88 PSMC6 FBXO11 PRKDC POMK CREBBP EP300 SMAD1 DNMT1 | 3.61e-05 | 1475 | 56 | 17 | M19806 |
| Pathway | PID_HES_HEY_PATHWAY | 3.82e-05 | 48 | 56 | 4 | M288 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 7.51e-05 | 21 | 56 | 3 | M39593 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.45e-04 | 26 | 56 | 3 | MM14793 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.54e-04 | 5 | 56 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.54e-04 | 5 | 56 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.54e-04 | 5 | 56 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.54e-04 | 5 | 56 | 2 | M27228 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.30e-04 | 6 | 56 | 2 | M22062 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.21e-04 | 7 | 56 | 2 | MM1573 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 3.26e-04 | 34 | 56 | 3 | M39771 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.27e-04 | 8 | 56 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 4.27e-04 | 8 | 56 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 4.27e-04 | 8 | 56 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 4.27e-04 | 8 | 56 | 2 | M46443 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.62e-04 | 91 | 56 | 4 | M27101 | |
| Pathway | PID_FOXM1_PATHWAY | 5.29e-04 | 40 | 56 | 3 | M176 | |
| Pathway | REACTOME_SUMOYLATION | 5.44e-04 | 169 | 56 | 5 | MM14919 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 5.48e-04 | 9 | 56 | 2 | MM1366 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 5.48e-04 | 9 | 56 | 2 | M47451 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 6.11e-04 | 42 | 56 | 3 | M17541 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 6.83e-04 | 10 | 56 | 2 | M27945 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.33e-04 | 11 | 56 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 8.33e-04 | 11 | 56 | 2 | M48021 | |
| Pathway | REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING | 8.33e-04 | 11 | 56 | 2 | M42523 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 8.33e-04 | 11 | 56 | 2 | M26924 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | UBE2G2 UBE2H STAG1 INCENP RBBP5 SHISA5 NUP88 PSMC6 FBXO11 PRKDC POMK EP300 SMAD1 DNMT1 | 8.36e-04 | 1389 | 56 | 14 | MM15307 |
| Pathway | BIOCARTA_CARM1_PATHWAY | 9.97e-04 | 12 | 56 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 9.97e-04 | 12 | 56 | 2 | M27765 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 9.97e-04 | 12 | 56 | 2 | M12851 | |
| Pathway | PID_AR_TF_PATHWAY | 1.21e-03 | 53 | 56 | 3 | M151 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.21e-03 | 53 | 56 | 3 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.35e-03 | 55 | 56 | 3 | M39351 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.37e-03 | 14 | 56 | 2 | M27808 | |
| Pathway | KEGG_CELL_CYCLE | 1.52e-03 | 125 | 56 | 4 | M7963 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.57e-03 | 15 | 56 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.57e-03 | 15 | 56 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M953 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 1.65e-03 | 59 | 56 | 3 | M261 | |
| Pathway | PID_FAK_PATHWAY | 1.65e-03 | 59 | 56 | 3 | M281 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.65e-03 | 59 | 56 | 3 | M39886 | |
| Pathway | REACTOME_GASTRULATION | 1.70e-03 | 129 | 56 | 4 | M46433 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.79e-03 | 16 | 56 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.79e-03 | 16 | 56 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.79e-03 | 16 | 56 | 2 | M8516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.79e-03 | 16 | 56 | 2 | M27940 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 1.79e-03 | 16 | 56 | 2 | M46428 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.03e-03 | 17 | 56 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.03e-03 | 17 | 56 | 2 | M48025 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 2.08e-03 | 64 | 56 | 3 | M27046 | |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 2.18e-03 | 65 | 56 | 3 | MM15490 | |
| Pathway | PID_RB_1PATHWAY | 2.18e-03 | 65 | 56 | 3 | M279 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.27e-03 | 233 | 56 | 5 | M27099 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 2.28e-03 | 66 | 56 | 3 | M101 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.28e-03 | 18 | 56 | 2 | M26942 | |
| Pubmed | 1.09e-08 | 3 | 78 | 3 | 10673036 | ||
| Pubmed | Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. | 4.17e-08 | 16 | 78 | 4 | 22780989 | |
| Pubmed | E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. | 1.08e-07 | 5 | 78 | 3 | 10497242 | |
| Pubmed | Neurogenin promotes neurogenesis and inhibits glial differentiation by independent mechanisms. | 1.08e-07 | 5 | 78 | 3 | 11239394 | |
| Pubmed | 2.16e-07 | 6 | 78 | 3 | 10887155 | ||
| Pubmed | A unique SUMO-2-interacting motif within LANA is essential for KSHV latency. | 3.77e-07 | 7 | 78 | 3 | 24278015 | |
| Pubmed | 4.84e-07 | 425 | 78 | 9 | 24999758 | ||
| Pubmed | 9.03e-07 | 9 | 78 | 3 | 16801560 | ||
| Pubmed | 9.03e-07 | 9 | 78 | 3 | 18241125 | ||
| Pubmed | METAP1 ARHGAP5 NR2C1 NSMF CELSR3 STAG1 MORF4L1 FBXO11 PRKDC CREBBP EP300 RUFY3 MAPK8IP3 DNMT1 | 9.25e-07 | 1285 | 78 | 14 | 35914814 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.26e-06 | 351 | 78 | 8 | 38297188 | |
| Pubmed | 1.77e-06 | 11 | 78 | 3 | 24349473 | ||
| Pubmed | 2.35e-06 | 12 | 78 | 3 | 12189208 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.97e-06 | 2 | 78 | 2 | 34845315 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19729597 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 39287984 | ||
| Pubmed | The mouse mutation severe combined immune deficiency (scid) is on chromosome 16. | 4.97e-06 | 2 | 78 | 2 | 2908877 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 20717166 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 25893291 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11559821 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 32576962 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19822209 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24522976 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 4.97e-06 | 2 | 78 | 2 | 21847097 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 4.97e-06 | 2 | 78 | 2 | 34813504 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 20301699 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24639469 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 37816914 | ||
| Pubmed | CAS directly interacts with vinculin to control mechanosensing and focal adhesion dynamics. | 4.97e-06 | 2 | 78 | 2 | 23974298 | |
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 4.97e-06 | 2 | 78 | 2 | 11438528 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 10918613 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 35502657 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 31898871 | ||
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 4.97e-06 | 2 | 78 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 4.97e-06 | 2 | 78 | 2 | 27881443 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 19272189 | ||
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 4.97e-06 | 2 | 78 | 2 | 32690000 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30953353 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21803292 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9811832 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24089570 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15706485 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 4.97e-06 | 2 | 78 | 2 | 39266679 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22303793 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 4.97e-06 | 2 | 78 | 2 | 34019788 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15860545 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 4.97e-06 | 2 | 78 | 2 | 24551300 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 33911074 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9018065 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 24648406 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30135524 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 4.97e-06 | 2 | 78 | 2 | 16596650 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 23288882 | ||
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 4.97e-06 | 2 | 78 | 2 | 29217654 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 10049825 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 4.97e-06 | 2 | 78 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 4.97e-06 | 2 | 78 | 2 | 29170789 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 21555743 | ||
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 4.97e-06 | 2 | 78 | 2 | 12646247 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 15304484 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 11867645 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 3416632 | ||
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 4.97e-06 | 2 | 78 | 2 | 11963968 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 4.97e-06 | 2 | 78 | 2 | 12696060 | |
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 4.97e-06 | 2 | 78 | 2 | 36109165 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 12242694 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 31182547 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 30635043 | ||
| Pubmed | p300 Functions as a coactivator of transcription factor GATA-4. | 4.97e-06 | 2 | 78 | 2 | 11481322 | |
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 4.97e-06 | 2 | 78 | 2 | 27648933 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 4.97e-06 | 2 | 78 | 2 | 37314181 | |
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 4.97e-06 | 2 | 78 | 2 | 12397173 | |
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 4.97e-06 | 2 | 78 | 2 | 15641773 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 9733868 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 4.97e-06 | 2 | 78 | 2 | 33063428 | |
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 34506759 | ||
| Pubmed | 4.97e-06 | 2 | 78 | 2 | 22177454 | ||
| Pubmed | NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain. | 7.21e-06 | 17 | 78 | 3 | 34637754 | |
| Pubmed | 1.00e-05 | 332 | 78 | 7 | 37433992 | ||
| Pubmed | A multiprotein complex necessary for both transcription and DNA replication at the β-globin locus. | 1.40e-05 | 21 | 78 | 3 | 20808282 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 18070920 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 11994297 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 20851880 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 27903646 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 12748286 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 24340053 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 19273602 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 15649887 | ||
| Pubmed | DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes. | 1.49e-05 | 3 | 78 | 2 | 26951377 | |
| Pubmed | Global loss of imprinting leads to widespread tumorigenesis in adult mice. | 1.49e-05 | 3 | 78 | 2 | 16226703 | |
| Pubmed | CBP/p300 and SIRT1 are involved in transcriptional regulation of S-phase specific histone genes. | 1.49e-05 | 3 | 78 | 2 | 21789216 | |
| Pubmed | Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. | 1.49e-05 | 3 | 78 | 2 | 12050117 | |
| Pubmed | Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. | 1.49e-05 | 3 | 78 | 2 | 16237459 | |
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 19041714 | ||
| Pubmed | 1.49e-05 | 3 | 78 | 2 | 28673974 | ||
| Interaction | CTBP1 interactions | KLF12 AMPD2 UBE2H RBBP5 NTAQ1 RTN4 FBXO11 CREBBP EP300 DNMT1 | 3.25e-06 | 406 | 77 | 10 | int:CTBP1 |
| Interaction | EGR2 interactions | 4.09e-06 | 171 | 77 | 7 | int:EGR2 | |
| Interaction | PSG8 interactions | 1.79e-05 | 41 | 77 | 4 | int:PSG8 | |
| Interaction | NCOA6 interactions | 1.95e-05 | 145 | 77 | 6 | int:NCOA6 | |
| Interaction | GSC interactions | 2.07e-05 | 87 | 77 | 5 | int:GSC | |
| Interaction | RBBP7 interactions | NR2C1 UBE2H STAG1 RBBP5 MORF4L1 GATA4 CREBBP EP300 DNMT1 BAHCC1 | 2.25e-05 | 507 | 77 | 10 | int:RBBP7 |
| Interaction | EWSR1 interactions | BCL9L DENND2A UBE2H INCENP CECR2 GATA4 ANO1 PSMC6 ZSWIM4 CREBBP EP300 VCL SMAD1 | 3.58e-05 | 906 | 77 | 13 | int:EWSR1 |
| Interaction | NEUROG1 interactions | 4.97e-05 | 19 | 77 | 3 | int:NEUROG1 | |
| Interaction | CRX interactions | 5.28e-05 | 254 | 77 | 7 | int:CRX | |
| Interaction | KAT2A interactions | 6.55e-05 | 180 | 77 | 6 | int:KAT2A | |
| Interaction | HDAC1 interactions | NR2C1 STAG1 RBBP5 MORF4L1 NUP88 GATA4 PSMC6 NUDCD1 POMK CREBBP EP300 SMAD1 DNMT1 BAHCC1 | 6.92e-05 | 1108 | 77 | 14 | int:HDAC1 |
| Interaction | MSH6 interactions | 7.93e-05 | 271 | 77 | 7 | int:MSH6 | |
| Interaction | MTA1 interactions | 1.04e-04 | 283 | 77 | 7 | int:MTA1 | |
| Interaction | HBP1 interactions | 1.09e-04 | 123 | 77 | 5 | int:HBP1 | |
| Interaction | SMAD2 interactions | 1.10e-04 | 385 | 77 | 8 | int:SMAD2 | |
| Interaction | H3-3A interactions | NR2C1 UBE2H STAG1 INCENP RBBP5 MORF4L1 GATA4 PRKDC CREBBP EP300 DNMT1 | 1.24e-04 | 749 | 77 | 11 | int:H3-3A |
| Interaction | CSNK2B interactions | AMPD2 SETD2 UBE2H RBBP5 NTAQ1 U2SURP GATA4 CREBBP EP300 DNMT1 | 1.29e-04 | 625 | 77 | 10 | int:CSNK2B |
| Interaction | HOXB7 interactions | 1.31e-04 | 26 | 77 | 3 | int:HOXB7 | |
| Interaction | SPATA32 interactions | 1.43e-04 | 5 | 77 | 2 | int:SPATA32 | |
| Cytoband | 3p21.31 | 2.67e-05 | 100 | 78 | 4 | 3p21.31 | |
| Cytoband | 2p16.3 | 6.44e-04 | 22 | 78 | 2 | 2p16.3 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.24e-03 | 17 | 56 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.40e-03 | 18 | 56 | 2 | 91 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | SHD KLF12 CACNB1 RSPH3 NSMF UBE2H MANEAL ANO1 POU3F4 FOXN3 MAPKBP1 MAPK8IP3 | 1.41e-05 | 743 | 77 | 12 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.40e-05 | 447 | 77 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SHD KLF12 CACNB1 RSPH3 NSMF UBE2H CECR2 MANEAL ANO1 FOXN3 MAPKBP1 | 3.65e-05 | 688 | 77 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 6.26e-05 | 188 | 77 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | SHD KLF12 CACNB1 RSPH3 NSMF UBE2H MANEAL ANO1 FOXN3 MAPKBP1 POMK | 7.65e-05 | 747 | 77 | 11 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2 |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-05 | 181 | 78 | 5 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-05 | 189 | 78 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-05 | 189 | 78 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.04e-05 | 189 | 78 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.15e-05 | 191 | 78 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 192 | 78 | 5 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 192 | 78 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.20e-05 | 192 | 78 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.26e-05 | 193 | 78 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 196 | 78 | 5 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-05 | 196 | 78 | 5 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.68e-05 | 200 | 78 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.36e-04 | 149 | 78 | 4 | a34d095b8e0fe59d69d84e4fd2fe4ccb82f92e4f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-04 | 156 | 78 | 4 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 157 | 78 | 4 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 168 | 78 | 4 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 168 | 78 | 4 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 168 | 78 | 4 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 2.21e-04 | 169 | 78 | 4 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-04 | 170 | 78 | 4 | 09bcbc7eb3b1d35cf03f01ce2f2fe37373382dd4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-04 | 173 | 78 | 4 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-04 | 178 | 78 | 4 | 51d2188406f04329311b2efd1108fc36617a860e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.75e-04 | 179 | 78 | 4 | e860dca9b28ac5af61804bfd729cd39257cdb352 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 179 | 78 | 4 | 4a072526c3a524a7aed99bdb32a07a1ce1f48972 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 2.93e-04 | 182 | 78 | 4 | a5fd392178c2f533e265d2e3ce63b90c2553e4c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 182 | 78 | 4 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-04 | 182 | 78 | 4 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.99e-04 | 183 | 78 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.99e-04 | 183 | 78 | 4 | 9dfb398b9995d562864fe688861a831ada0814cd | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-04 | 183 | 78 | 4 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 3.05e-04 | 184 | 78 | 4 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.05e-04 | 184 | 78 | 4 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.11e-04 | 185 | 78 | 4 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.11e-04 | 185 | 78 | 4 | 512f489daeb3b72d4578dc6f4d0ebb5f38d5bbab | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.18e-04 | 186 | 78 | 4 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-04 | 186 | 78 | 4 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 3.18e-04 | 186 | 78 | 4 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-04 | 186 | 78 | 4 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-04 | 187 | 78 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.24e-04 | 187 | 78 | 4 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.24e-04 | 187 | 78 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.24e-04 | 187 | 78 | 4 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.24e-04 | 187 | 78 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | wk_08-11-Epithelial-PNS-MFNG+_DBH+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.31e-04 | 188 | 78 | 4 | d3d7d21d4fa39ac4106a164652673de1bef8662d | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.38e-04 | 189 | 78 | 4 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-04 | 189 | 78 | 4 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-04 | 190 | 78 | 4 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-04 | 190 | 78 | 4 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.44e-04 | 190 | 78 | 4 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-04 | 190 | 78 | 4 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-04 | 190 | 78 | 4 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.44e-04 | 190 | 78 | 4 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-04 | 191 | 78 | 4 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-04 | 191 | 78 | 4 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.58e-04 | 192 | 78 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.58e-04 | 192 | 78 | 4 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.58e-04 | 192 | 78 | 4 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.58e-04 | 192 | 78 | 4 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | wk_15-18-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.58e-04 | 192 | 78 | 4 | ab54d4bfc61ef7e3d765afe6e4a6d7011a301ecd | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.58e-04 | 192 | 78 | 4 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-04 | 193 | 78 | 4 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.65e-04 | 193 | 78 | 4 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.65e-04 | 193 | 78 | 4 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.65e-04 | 193 | 78 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.73e-04 | 194 | 78 | 4 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 195 | 78 | 4 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 195 | 78 | 4 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.80e-04 | 195 | 78 | 4 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.95e-04 | 197 | 78 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 197 | 78 | 4 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-04 | 197 | 78 | 4 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.95e-04 | 197 | 78 | 4 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.95e-04 | 197 | 78 | 4 | c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.95e-04 | 197 | 78 | 4 | bc37b8919f98dc18c2200834405f06823d965d78 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.02e-04 | 198 | 78 | 4 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.02e-04 | 198 | 78 | 4 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.02e-04 | 198 | 78 | 4 | ea6621a148a96c8ffa1a93a35c9e288545d2637a | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 4.02e-04 | 198 | 78 | 4 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.02e-04 | 198 | 78 | 4 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 4.10e-04 | 199 | 78 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.18e-04 | 200 | 78 | 4 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.18e-04 | 200 | 78 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.18e-04 | 200 | 78 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 4.18e-04 | 200 | 78 | 4 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.18e-04 | 200 | 78 | 4 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.18e-04 | 200 | 78 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.18e-04 | 200 | 78 | 4 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.18e-04 | 200 | 78 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.18e-04 | 200 | 78 | 4 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.18e-04 | 200 | 78 | 4 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.18e-04 | 200 | 78 | 4 | be83f442179ba4217d12f0458059586ff3130991 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.83e-06 | 180 | 78 | 7 | 6886_DN | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 5.66e-06 | 200 | 78 | 7 | 4820_UP | |
| Disease | Adenoid Cystic Carcinoma | 6.58e-06 | 100 | 77 | 5 | C0010606 | |
| Disease | Menke-Hennekam syndrome | 6.72e-06 | 2 | 77 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 6.72e-06 | 2 | 77 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 6.72e-06 | 2 | 77 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.72e-06 | 2 | 77 | 2 | C4551859 | |
| Disease | HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1 | 6.72e-06 | 2 | 77 | 2 | C4012050 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 6.72e-06 | 2 | 77 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 6.72e-06 | 2 | 77 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 6.72e-06 | 2 | 77 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 6.72e-06 | 2 | 77 | 2 | C0035934 | |
| Disease | Small cell carcinoma of lung | 1.23e-05 | 54 | 77 | 4 | C0149925 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2.00e-05 | 61 | 77 | 4 | C1961102 | |
| Disease | Hennekam syndrome (is_implicated_in) | 2.01e-05 | 3 | 77 | 2 | DOID:0060366 (is_implicated_in) | |
| Disease | Hennekam lymphangiectasia-lymphedema syndrome | 2.01e-05 | 3 | 77 | 2 | C0340834 | |
| Disease | congenital heart disease (biomarker_via_orthology) | 4.02e-05 | 4 | 77 | 2 | DOID:1682 (biomarker_via_orthology) | |
| Disease | hepatocyte growth factor-like protein measurement | 1.35e-04 | 38 | 77 | 3 | EFO_0008154 | |
| Disease | thioredoxin domain-containing protein 12 measurement | 1.46e-04 | 39 | 77 | 3 | EFO_0008298 | |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 1.86e-04 | 8 | 77 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | IGF-1 measurement | 2.87e-04 | 488 | 77 | 7 | EFO_0004627 | |
| Disease | Squamous cell carcinoma | 3.17e-04 | 124 | 77 | 4 | C0007137 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.07e-04 | 55 | 77 | 3 | C0079744 | |
| Disease | monocyte count | SETD2 UBE2H STAG1 TSPOAP1 CECR2 U2SURP PLCL2 PRKDC ONECUT1 MN1 DNMT1 | 6.11e-04 | 1320 | 77 | 11 | EFO_0005091 |
| Disease | Leukemia, Myelocytic, Acute | 1.11e-03 | 173 | 77 | 4 | C0023467 | |
| Disease | hydrocephalus (implicated_via_orthology) | 1.12e-03 | 19 | 77 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.12e-03 | 447 | 77 | 6 | C3714756 | |
| Disease | Prostatic Neoplasms | 1.14e-03 | 616 | 77 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.14e-03 | 616 | 77 | 7 | C0376358 | |
| Disease | gastric ulcer | 1.37e-03 | 21 | 77 | 2 | EFO_0009454 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 1.50e-03 | 22 | 77 | 2 | C1843687 | |
| Disease | basophil count | 1.66e-03 | 483 | 77 | 6 | EFO_0005090 | |
| Disease | testosterone measurement | METAP1 STAG1 CECR2 NTAQ1 NICN1 GATA4 FBXO11 FOXN3 ONECUT1 MGRN1 | 1.73e-03 | 1275 | 77 | 10 | EFO_0004908 |
| Disease | lymphocyte percentage of leukocytes | 1.76e-03 | 665 | 77 | 7 | EFO_0007993 | |
| Disease | osteoarthritis, hip | 1.82e-03 | 92 | 77 | 3 | EFO_1000786 | |
| Disease | albuminuria | 1.93e-03 | 94 | 77 | 3 | EFO_0004285 | |
| Disease | response to interferon | 1.94e-03 | 25 | 77 | 2 | EFO_0007859 | |
| Disease | Squamous cell carcinoma of esophagus | 1.99e-03 | 95 | 77 | 3 | C0279626 | |
| Disease | hearing impairment | 2.17e-03 | 98 | 77 | 3 | C1384666 | |
| Disease | Colorectal Carcinoma | 2.38e-03 | 702 | 77 | 7 | C0009402 | |
| Disease | Iniencephaly | 2.43e-03 | 28 | 77 | 2 | C0152234 | |
| Disease | Tethered Cord Syndrome | 2.43e-03 | 28 | 77 | 2 | C0080218 | |
| Disease | Spinal Cord Myelodysplasia | 2.43e-03 | 28 | 77 | 2 | C0344479 | |
| Disease | Exencephaly | 2.43e-03 | 28 | 77 | 2 | C0266453 | |
| Disease | Neurenteric Cyst | 2.43e-03 | 28 | 77 | 2 | C0027806 | |
| Disease | Acrania | 2.43e-03 | 28 | 77 | 2 | C0702169 | |
| Disease | Diastematomyelia | 2.43e-03 | 28 | 77 | 2 | C0011999 | |
| Disease | obsolete_red blood cell distribution width | RBBP5 SHISA5 MORF4L1 NICN1 RTN4 U2SURP PLCL2 ZCCHC2 EP300 SMAD1 | 2.58e-03 | 1347 | 77 | 10 | EFO_0005192 |
| Disease | Craniorachischisis | 2.61e-03 | 29 | 77 | 2 | C0152426 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MHVQEYGSDCPPPNQ | 1376 | Q09472 | |
| MAGRPHPYDGNSSDP | 1 | Q9BSF8 | |
| EGTMAPDHAAPYGVS | 426 | Q9P281 | |
| EPMEAQTHAPGPYAD | 81 | A8MXV6 | |
| EHASMHEYPGELGQP | 461 | Q02641 | |
| KYGQHPPDAVDEPQM | 366 | P26358 | |
| QDIYQVPPSAGMGHD | 176 | P56945 | |
| FDDPDNIPPYGDDMT | 4556 | Q6V0I7 | |
| GMHVQEYGSDCPPPN | 1411 | Q92793 | |
| ENYEGTMDPSQVPEH | 1291 | O60706 | |
| PYEHCEPSTMPGDLG | 306 | Q01433 | |
| PDFPESSEIPPSHMY | 766 | Q9BXF3 | |
| EIPDGPPVVAHYDMS | 236 | Q96B23 | |
| AQLHGMEDPTQPDYE | 391 | Q9UF12 | |
| PSPMPEYLNVHYIGE | 381 | P13056 | |
| YDPVSMSPNPDAGEE | 1636 | O95153 | |
| LQELMAGPGHFDPYN | 176 | P05177 | |
| VPHYAAIEPDGNGLM | 231 | Q96RS6 | |
| ADHPDAPMSQVYGAP | 286 | Q9UBU8 | |
| YLNMPPVDIDGCHSP | 166 | A5PLL1 | |
| DGEPPYFSDSPVQAM | 596 | Q9NQU5 | |
| PDYADHPLGMSESEQ | 106 | P53582 | |
| YPPGEMFLDSDVNPE | 821 | Q9UPT6 | |
| HRAPPKINPDNYGMD | 811 | Q9NQS7 | |
| GPHCSPDDYIPMNSG | 406 | Q8WWW8 | |
| TPHPEGYLFGENMDL | 46 | O60291 | |
| PPEMPQYGEENHIFE | 11 | Q96MA6 | |
| SYDLNSNDPDPMPHP | 206 | Q16549 | |
| GLPHYAHPGAAMPTD | 196 | Q9UBC0 | |
| MEYHQPEDPAPGKAG | 1 | Q8N5J2 | |
| AYSGHDGSPEMQPAP | 51 | Q6X4W1 | |
| ASLDAGSGEPPMDYH | 106 | Q5XXA6 | |
| YGPPPDAVQTSLMDE | 416 | Q15291 | |
| MTPPGDQQPHEVYSH | 336 | P49335 | |
| HGDRAPLASYPMDPH | 41 | Q9BZG2 | |
| AMAANHGPPPGAYEA | 6 | P43694 | |
| PPMKENPYEDIELHG | 376 | Q9ULE3 | |
| TGEHVPGSEMPVPDY | 581 | P10912 | |
| MHPEPGKFYQINPEE | 211 | Q86XK2 | |
| DDDTPPSPAHSDMPY | 91 | O00409 | |
| PSPAHSDMPYDARQN | 96 | O00409 | |
| SYPEAMDLGSGDDHP | 376 | Q6UXH8 | |
| LQQHYPSGMALPPED | 1251 | Q86UU0 | |
| PAHDAGDNNIYEVMP | 231 | Q7Z692 | |
| YPPGMADDNGEPSDD | 191 | Q5VSG8 | |
| EDGIVYPEPSDNPTM | 951 | O60336 | |
| GSPNVHNYPDMEAVP | 41 | Q9Y4X4 | |
| AVDPDEGPNAHIMYQ | 1091 | Q9NYQ7 | |
| MDEPESYPDEIGPKH | 121 | Q8IYK4 | |
| SHPGYEAAMADRPQP | 41 | Q8N0W7 | |
| HESDLPPMPGEAVEY | 176 | Q8IVF4 | |
| MEGNGPAAVHYQPAS | 1 | Q96HA8 | |
| PLPMHPAAEDNYGYD | 296 | Q99567 | |
| QPPFAEGYEHMAESQ | 146 | Q10571 | |
| HEPENPPPYEEAMSV | 651 | Q9NQC3 | |
| TPDPEPTHEDPNYLM | 51 | Q7L099 | |
| DAQPHPAPPDDGYME | 111 | Q96IW2 | |
| DHTRHMDPGYPAQSP | 456 | Q9ULZ9 | |
| HGSYSPPPEEAMPFE | 91 | Q5JWF2 | |
| DGPDNEPVIYTGHTM | 476 | Q9UPR0 | |
| HPPGMQYPDLQQDAR | 916 | O94933 | |
| YCLMPDPHSEEGAQE | 81 | Q9BSH3 | |
| AQPMGPPAYHETLAG | 201 | Q8N114 | |
| PYGEDVPFHDDLMPS | 261 | Q9H5K3 | |
| HPEDMDPSDNYAEPI | 1081 | Q13017 | |
| NVSPYMEYHPGGEDE | 81 | Q7L1T6 | |
| MAHPAPLAPGAASAY | 91 | P31271 | |
| AYLPPEDPMTQDGSQ | 226 | Q15797 | |
| PPLNPYLHGMSEEQE | 506 | O15042 | |
| PQTPYANGLVHDPVM | 1076 | Q9C0B9 | |
| DSLTQPDEEPMHYGN | 176 | Q86UC2 | |
| PNPIDPLNGDAAAMY | 116 | P62256 | |
| PSPPYHSMMGDDEDA | 71 | Q6NXS1 | |
| AAGFPVPPDMEDDYE | 936 | P18206 | |
| DEDSGDYPLTMPGPQ | 156 | Q8WVM7 | |
| KMGDFYDPEHPTPEE | 11 | Q9BYW2 | |
| DYPNPMFEHPLSECE | 2571 | P78527 | |
| DPLVYNMSHEDPGNV | 116 | P62333 | |
| SILHAPGDDPMGYES | 91 | P60604 | |
| MYSSLGYPPPEGEHD | 81 | Q9H7M6 |